T655-0135 Screening compound: 3-(3,5-dimethyl-1H-pyrazol-1-yl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-propanone

T655-0135 Screening compound: 3-(3,5-dimethyl-1H-pyrazol-1-yl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-propanone
T655-0135 Screening compound: 3-(3,5-dimethyl-1H-pyrazol-1-yl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-propanone alternative view

Chemical Structure Depiction of ChemDiv screening compound T655-0135
3-(3,5-dimethyl-1H-pyrazol-1-yl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-propanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0135

Molecular Formula

C21H31N5O3 (C21 H31 N5 O3)

Compound Name

3-(3,5-dimethyl-1H-pyrazol-1-yl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-propanone

IUPAC name

3-(35-dimethyl-1H-pyrazol-1-yl)-1-{4-[5-(propan-2-yl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decan-2-yl}propan-1-one

SMILES

CC(C)c1nnc(C(CN(C2)C(CCn3nc(C)cc3C)=O)C22CCOCC2)o1

InChI

InChI=1S/C21H31N5O3/c1-14(2)19-22-23-20(29-19)17-12-25(13-21(17)6-9-28-10-7-21)18(27)5-8-26-16(4)11-15(3)24-26/h11,14,17H,5-10,12-13H2,1-4H3/t17-/m0/s1

InChI Key

HMUQJFBJUMCZAY-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD29002593

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

401.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.045

Distribution Coefficient, logD

1.045

Water Solubility, LogSw

-1.23

Polar Surface Area

68.922

Acid Dissociation Constant (pKa)

23.21

Base Dissociation Constant (pKb)

4.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

71.43

T655-0135 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T655-0135 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T655-0135?
Check Price and Availability of T655-0135, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T655-0135 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T655-0135
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T655-0135
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T655-0135 available by request